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Abstract
We developed simulation methodology to assess eventual therapeutic efficiency of exogenous multipara-
metric changes in a four-component cellular system described by the system of ordinary differential equations.
The method is numerically implemented to simulate the temporal behavior of a cellular system of multiple
myeloma cells. The problem is conceived as an inverse optimization task where the alternative temporal
changes of selected parameters of the ordinary differential equations represent candidate solutions and the
objective function quantifies the goals of the therapy. The system under study consists of two main cellular
components, tumor cells and their cellular environment, respectively. The subset of model parameters closely
related to the environment is substituted by exogenous time dependencies - therapeutic pulses combining con-
tinuous functions and discrete parameters subordinated thereafter to the optimization. Synergistic interaction
of temporal parametric changes has been observed and quantified whereby two or more dynamic parameters
show effects that absent if either parameter is stimulated alone. We expect that the theoretical insight into un-
stable tumor growth provided by the sensitivity and optimization studies could, eventually, help in designing
combination therapies.
Keywords: multiple myeloma, tumor and environment, osteoblast and osteoclast populations, ordinary dif-
ferential equations, minimax optimization, sensitivity analysis
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1 Introduction
Mathematical models of cancer are widely used to get insight into dynamics of cancer initiation and progression
whereby they help researchers to design new therapeutical strategies [1, 2, 3, 4]. As a consequence of ongo-
ing accumulation of relevant biological knowledge, as well as availability of prognostic variables, complexity
of mathematical models in tumor biology constantly increases. At the same time, the bottom-up derivation of
the relation between microscopic level and macroscopic behavior is far from straightforward. The balance be-
tween biological relevance and mathematical complexity is typically achieved by means of iterations containing
addition or omission of algebraic expressions in the respective model. Despite the vast majority of iterative
model-modifying operations is motivated by relatively well understood short-term effects of the respective vari-
ables and algebraic terms, too many details can, paradoxically, make the overall interpretation of the numerical
results more difficult [5].
Due to nonlinear interactions, that pose the most difficult obstacle (except the fixed points), the long-term or
large-scale outcomes cannot be usually interpreted without detailed simulations. Along with progress in onco-
logical experimental studies and synthesizing of available information, emerging field of multi-scale modeling
[6] provides novel computational strategies of exploring cancer biology simultaneously with anticancer thera-
pies. Although this type of approach enables to reduce the number of degrees of freedom, the problem associated
with too many parameters and their relevance persists, which is the common problem in most cancer simulation
models and methodologies, thus requiring to address the issue of parametric uncertainty, unidentifiability and
relevance [5, 7].
Motivated by these general unresolved questions of parametric importance, we developed the specific the-
oretical approach based on the model of bone remodeling by Komarova et al. [8] and its phenomenological
extension applied to multiple myeloma (MM) bone disease [9]. The above models illustrate the association of
incremental incorporation of novel biological information with an increase in the number of the parameters. It
follows that to control particular scenario (outcome) by the parameters of the model, it is essential to estimate
the relevance of the specific parameters and their meaningful groupings. The issue of parametric relevance is
especially challenging from the point of view of the therapy design. Within the context of mathematical models
of cancer or tumor growth, there is a systematic effort towards identification of the appropriate parameters in
order to achieve, hopefully, therapeutic effects by parametric modifications [1].
The leitmotiv of here proposed methodology consists in the idea that coordinated multiparametric (high-
dimensional) changes can positively, in a therapeutic sense, effect cell populations. Most of the previous theoret-
ical studies of cancer have focused primarily on the virtual therapeutic interventions performed via variations of
parameters which describe drug-induced proliferation, necrosis or apoptosis (see Ref.[1] and references therein).
Since non-linear systems, including the cancer models [10], show a wide range of emerging and unstable behav-
iors, we assume that not yet fully understood area of therapeutic options can be much more fruitful and more
structured than intuitively expected [11].
To overcome the existing barriers to treatment, such as the resistance to chemotherapy, it seems important
to explore more advanced and universal strategic options (see e.g. [12, 13, 14]). Deeper understanding of their
impact might be achieved by combining knowledge from complementary research fields, such as optimization
theory, inverse problems [15], and sensitivity analysis [16, 17, 18, 19, 20, 21, 22, 23, 24].
2
In the present study we pursue the idea of multidimensional investigation of the global parametric sensitivity
of cancer population models. Our method extends the range of methods for the sensitivity analysis of the systems
of nonlinear ordinary differential equations (ODEs). Therefore, instead of application of standard analysis of
the respective ODEs system, we are interested in the specific global parametric sensitivity analysis [23] which
can be seen as a way to propose a qualitatively new therapies. Despite obvious differences in the technical
and implementation details, simultaneous use of the optimization and sensitivity analysis is commonly applied
feature [16, 19].
To put forward the above ideas, we apply them to analyze MM bone disease. In healthy bone tissue, the
bone homeostasis is maintained (or re-established after fracture or microscale damages) by many coordinated
actions at cellular and molecular levels, summarily called the bone remodeling [25]. The process maintains the
balance between removal of the bone tissue (resorption) and the formation of new tissue (ossification). The
bone remodeling involves two crucial cell types - osteoclasts (OCs) and osteoblasts (OBs). The former cells are
responsible for disassembling the old bone tissue, the latter for synthesizing the new tissue. The imbalance be-
tween intensities of the two processes leads to bone diseases, such as osteoporosis or bone cancer. Physiological
numbers of OCs and OBs are guaranteed by their mutual influence via autocrine and paracrine signaling. Due
to serious health implications of the MM cancer, several mathematical models were developed to understand
nonlinear dynamics of the OCs and OBs production, homeostasis and decay [26, 27, 28, 29, 30], proposing al-
ternative equations to describe the system. The assembly composed of many coupled submodels [31] has been
considered to adequately describe calcium homeostasis and intracellular signaling as occurring in the process of
bone remodeling. The analysis of homeostatic control also means a better understanding of MM, which is often
manifested by hypercalcemia [32].
Here presented computational considerations derive from the ODEs model by Komarova et al. [8] describing
population dynamics of OCs and OBs in healthy tissue. Their parametrization of the net effectiveness of the
OCs and OBs autocrine and paracrine factors, such as TGF−β (one of the classes of polypeptide transforming
growth factors), RANKL (the receptor activator of nuclear factor kappa-B ligand), and OPG (osteoclastogenesis
inhibitory factor), was used in the recent mathematical model of multiple myeloma by Koenders and Saso [9].
Therein, the authors augmented the above model by Komarova et al. [8] by including the population of myeloma
cells with the feedback to the OCs proliferation and the OBs decay into the model. Moreover, the population
of so-called joint cells (JCs) also called OCs-MM hybrid cells [33, 34], formed when one OC and one MM cell
meet, was included into the extended set of equations [9]. This model also includes the tumoral feedback on the
paracrine interactions, interactions of OBs and OCs [35]. The OCs-MM hybrid cells co-cultures are considered to
contribute significantly to the formation of bone-resorbing OCs and bone destruction in the MM case. Although
widely discussed phenomena of intratumoral MM heterogeneity [30, 36], phenotypic plasticity [29] and drug
resistance can decisively influence the treatment, we leave these aspects to further research. On the other hand,
formation of JCs belonging to the wide class of pathological cell fusion processes in cancer [37, 38], already
captured at some basic level in [9], can be considered as an alternative mechanism contributing to the phenotypic
heterogeneity thereby increasing the chemical resistance and metastatic potential. Promising approach to the
MM analysis represents the agent based model introduced in [29] which incorporates DKK1-Wnt-OPG/RANKL
pathway and cytokine stimulation. The main strength of the model consists in the study of therapeutic effects of
Lidamycin, glucocorticoids and Anti-DKK1 mAb (BHQ880). Unfortunately, it is rather difficult to compare or
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associate this type of models to ODEs.
In the present work we address the problems discussed in [9] from different perspectives and research in-
terests. The emphasis is placed on the specific aspects of the sensitivity analysis, parametric relevance, and
optimization of therapeutic interventions. Here applied variant of the sensitivity analysis uses therapeutically
relevant parametric moves (pulses) determined as the worst-case optimization outputs.
To develop the efficient therapeutic schedule, one implicitly faces to several, sometimes conflicting [39] or
overlapping, objectives which must be considered simultaneously. Regarding this, our motivation for the opti-
mization of parametric combinations is, apart from the search for the efficient solution, to formulate the method-
ological multi-objective framework that may provide basis for further studies. Despite intuitive plausibility of
the multi-objective formulation, solutions of the majority of multi-objective problems are not straightforward, as
different paradigms often lead to different solutions. There is a variety of methods how to quantify the quality
of the respective solution which is expected to fulfill simultaneously a few objectives [40]. Among them, the
scalarization approach [41] which leads to a compromise single-objective formulation is one of the widely used
practices. From the point of view of the reliability of the results, the degree of consistency (stability) achieved
through diverse scalarizations is important. In the most favorable circumstances, the scalarization points to the
single solution on the Pareto front.
In our paper, in addition to detailed analysis of the worst-case "minimax" scalarization, we present the al-
ternative numerical experiments with the optimization of single-objective functions based on the aggregation
transforms of several objectives [42]. In order to avoid uncertainty in the interpretation of our results, we use op-
timization that does not use stochastic sampling and is intentionally limited to generating deterministic outputs.
To analyze the respective non-differentiable scalarizations, we employed the comprehensive direct grid search
which evaluates the pair of purposefully constructed objective functions at each grid point of some feasible para-
metric region. This choice reflects the recent trends in machine learning [43, 44] where the grid search variants
also known as hyperparameter searches receive increasing attention.
The main aim of our study is to bring interesting alternative approach which could stimulate further re-
search in the respective direction instead of demonstrating superiority of the specific optimization algorithm.
Systematic analysis performed by the grid search technique can help to find parametric boundaries within which
improvements can be done (even if highly diluted grids are used). We note that, at this stage, the independence
of the grid search technique on the initial conditions with no tendency of being trapped in a local optimum vin-
dicates its (low) computational performance (nevertheless, in sec. 6.1 we discuss the hybrid discrete-continuous
optimization methodology which has significant potential to improve the coarse grid results).
The theoretical background to our considerations is the four cell population model [9] described by the
system of four ODEs written in the normal form
dC
dt
= RC(T,C,B) ,
dB
dt
= RB(T,C,B) , (1)
dT
dt
= RT (C, T, J) ,
dJ
dt
= RJ(C, T, J) ,
where the respective rates of change of the four populations, C,B, T, J , referring to the population of OCs (C),
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OBs (B), MM (T ) and JC (J), respectively, have the explicit form
RC ≡ αC(1 + hCTT )CgCCBgCB − βCC − αJCT , (2)
RB = αB(1− hBTT )CgBCBgBB − βBB ,
RT ≡ αTCgTCT gTT − βTT − αJCT + κJJ ,
RJ ≡ αJCT − βJJ .
This autonomous system couples population number of the OCs, MM cells, and JCs in the representative vol-
ume of bone marrow basic multicellular units (BMU); α•,β• represent activities of the cell production and
removal. The power-law nonlinear structure proposed by [8] of the interactions is parametrized by g•• which
represent the effectiveness of the OCs and OBs autocrine and paracrine factors. Increased sensitivity of OCs sand
OBs cells due to the influence of MM cells is modeled by hCT parameter. The interpretation behind the term
hCTTC
gCCBgCB is that MM cells stimulate bone metabolism and bone marrow micro-environment by means of
RANKL, decrease in OPG expression and production of chemokines MIP−1α (human macrophage inflamma-
tory protein), MIP−1β (macrophage inflammatory protein-1), and SDF−1α (stromal cell-derived factor) [9, 45].
Furthermore, the term (−hBT )TCgBCBgBB describes how MM cells suppress OB function by the secretion of
OB inhibiting factors, such as Wnt inhibitors DKK−1 and sFRP−2. The parameter κJ in the term κJJ denotes
the backward transformation rate of the JCs into MM cells with the specific assumption [9] that while MM cells
survive dissociation, OCs are not recreated, which means that there is no adequate term ∝ J in the RC [9].
The paper is organized as follows. In the section 2 we introduce basics of the methodology including the
parametrization of symmetric pulses and the form of the objective function. In the section 3 we present numerical
results obtained for given parametric settings. The alternative scalarizations of the multi-objective problem
are discussed in sec.4. In section 5 the alternative objective function with the regularization penalty term to
minimize toxic side effects (at some stylized level) of the therapies is studied. The model of the more realistic
exogenous asymmetric therapeutic pulses is introduced in sec. 6, where we also provide extensive comparison
of the impact of symmetric and asymmetric pulse forms, respectively, on the optimum obtained. In addition,
there are presented results of the optimization performed on the selected manifolds (which go beyond the results
provided by grid search). The generalization of synergistic quantification of the parametric pairs is presented as
well. Finally, the conclusions are presented. Two appendices provide additional information about the robustness
of optima in periodic environments and numerical accuracy of the calculations.
2 The methodology
In this section we provide methodological details of our approach. The main aim of our work is to formalize
and analyze the time-varying influence of the populations of OCs and OBs (viewed as the environment) on the
populations of tumoral cells (including the joint cells) via autocrine and paracrine interactions and, consequently,
to exploit this framework to drive dynamics of the tumor cells population towards required direction.
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2.1 The equilibrium approximation and short-time dynamics
Without sufficient knowledge of symmetry or invariance, or without significant simplifications the numerical
solution is, in principle, the only universal option to study population dynamics (Eqs. 1) under very general non-
linear conditions. Nevertheless, some partial insights into the tumor behavior can be achieved without actually
solving the corresponding ODEs numerically by starting with the static equilibrium analysis and then proceeding
with approximate dynamic considerations.
The information about equilibrium enables to derive long-term trends in overall dynamics. Although the
system of the transcendental equations RX = 0; X ∈ {C,B, T, J} with RX given by Eq.(2) presents no
computational difficulty, the problem is that the system does not provide steady-state solutions (fixed points) in
the explicit form. Analytical solvability can be achieved exclusively for the choice gTC = 0 and J = 0 [28, 9].
Discussion about the stability is postponed to the subsection 3.1.1. Despite its biological limitations, the above
approximation is useful as an initial guess for more advanced formula. In such case the equilibrium solution may
be expressed as
T (0)eq =
(
αT
βT
) 1
1−gTT
, (3)
C(0)eq = G
(
αC
βC
,
αB
βB
,
αT
βT
, 1− gBB, gCB, gxy
)
,
B(0)eq = G
(
αC
βC
,
αB
βB
,
αT
βT
, gBC , 1− gCC , gxy
)
,
where
G(x, y, gx, gy, gxy) = [x(1 + hCTT (0)eq )]
gx
gxy + [y(1− hBTT (0)eq )]
gy
gxy (4)
is the auxiliary function with the fixed argument gxy ≡ gCC(gBB−1)−gCBgBC+1. The formula emphasizes the
scaling dependence on the ratios of the proliferative/apoptotic rates αT /βT , αB/βB , αC/βC and the exponents
(1 − gBB)/gxy, gCB/gxy, gBC/gxy, (1 − gCC)/gxy. The equilibrium becomes, obviously, not tumor-free, as
αT 6= 0. When the simplifying assumption gTC = 0 is relaxed, the reliability of the formula for T (0)eq can
be further improved in an iterative way by revisiting condition RT = 0 and using the initial approximation
C ' C(0)eq . Owing to the above steps, the improved approximation for tumoral population number T (0,+)eq reflects
the impact of OCs as follows
T (0,+)eq = T
(0)
eq
 (C(0)eq )gTC
1 + αJβT C
(0)
eq (1− κJβJ )
 11−gTT , (5)
J (0,+)eq =
αJ
βJ
C(0)eq T
(0,+)
eq ,
where the population number J (0,+)eq is obtained from RJ = 0. In addition, we see that the above improvements
of Eq.(3) exhibit the scaling form with arguments αJ/βT , κJ/βJ and αJ/βJ . The approximate equilibrium
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solution of this type implicates the possibility of exploiting the influence of environmental characteristics C(0)eq
to affect the population of tumoral cells described by the T (0,+)eq and J
(0,+)
eq variables.
The essence of the environmental concept can also be captured analytically by examining a short-time
nonequilibrium picture of environmental influence, which is discussed below. The straightforward quantification
of the endogenous (edg) tumor response to the environment can be quantified by the two-time population ratios
defined by
fedgY (t, t+ ∆t)
def
=
Y (t+ ∆t)
Y (t)
, Y (t) ∈ {T (t), J(t)} (6)
considered for both tumoral population variants Y (t) and sufficiently small ∆t. In subsection 2.4.1 is the above
preliminary concept revisited [see Eq.(18) in further] and discussed for larger separation intervals, i.e. for ∆t→
(tE − tS).
Deeper understanding of the linkages between the environmental populations B,C and the responses of
population T can be obtained simply by using the truncated short time Taylor expansion
fedgY (t, t+ ∆t) = 1 +
∆tRY (t)
Y (t)
+
(∆t)2
2Y (t)
dRY
dt
+O(∆t3) . (7)
As will become clear later on, sufficient evidence of environmental influence can be obtained by expanding
fedgY (t, t+ ∆t) into ∆t
2 order at least.
The first order represented by dT/dt = fedgT ∼ RT (C, T, J)/T , dJ/dt = fedgJ ∼ RJ(C, T, J)/J confirms
that C influences dT/dt and dJ/dt while the impact of the changes due to environmental variable B remains
hidden. By means of the straightforward differentiation, the coefficients∼ dRTdt , dRJdt corresponding to ∆t2 order
from Eq.(7) can be expressed
1
T
dRT
dt
= αTC
gTC−1T gTT−2(gTCTRC + gTTCRT ) (8)
− αJ
(
RC +
C
T
RT
)
+ κJ
RJ
T
,
1
J
dRJ
dt
= αJ
(
T
J
RC +
C
J
RT
)
− βJRJ
J
.
As both the above right-hand sides include RC ≡ RC(T,C,B), the respective rates depend not only on C (as in
the first order case) but onB as well, which makes the causal relation between environmental (C,B) and tumoral
(T, J) populations more explicit. The short-time causality between exogenous parameter-induced environmental
changes and tumor subsystems that closely applies to the present work can be captured in an analogous way.
2.2 Sensitivity analysis and inverse/optimization task of ODEs system
The utmost ambition of our work is the proposal of a numerical procedure that can be viewed as a kind of global
sensitivity analysis designed for specific ODEs. We identify the most sensitive parameters or their combinations
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(a)
T J
C B
environment: χE → χ˜E(t, s)
tumor
fJ(s)
fT (s)
scalarization
f(s)
optimization
s
smin
(b)
E
T
conceptualization
Figure 1: Schematic plot showing interactions (oriented graph edges) between the population numbers
C,B, T, J , as described by Eqs.(1), (2). The topological representation of the algebraic structure of interac-
tions and direct causal relations is presented in the part (a). As RT (C, T, J) does not include B, the directed
link between nodes B and C absents. The links belong to the dependencies of the population rates [see Eqs.(1)].
The dynamics of environment is affected by the six pivotal parameters from Eq.(9) later replaced by smooth
exogenous pulses [see Eqs.(10),(13)]. The scheme also clarifies the influence of discrete s (string) parameters
from Eq.(12) which determine the relations between C,B (environment) and the tumoral populations T , J . The
scheme is supplemented by the computational aspects related to the choice of the objective functions fT , fJ ,
their scalarization (see subsection 2.4.1 and sec.4) and optimization leading to the optimal smin [see Eq.(20)].
In part (b) we depict the nodes corresponding to the conceptual framework from section 7 where the only pair
of abstract population vectors T (t), E(t) admits encompassing more general domain of population models with
environments.
as potential intermediaries for an indirect virtual therapeutic intervention. For our purposes, which are mainly
illustrative, the time-consuming search for the most influential and, hopefully, therapeutically promising para-
metric combinations is highly simplified. The parametric continuum is discretized and the search is conceived
as the grid optimization. For a specified discretization of the parametric space, eventual inaccuracies may result
from the numerical instabilities or stiffness of the respective ODE integrators [46].
As will be shown later, the optimality criteria are implicitly associated with the finite time interval, as the time
horizon plays an important role in the decision-making. Moreover, to guarantee that the optimization selects for
the solutions with controllable sparsity [47], the equality constraint or penalization term have been considered.
The main concepts of the approach may be summarized as follows:
1. The analysis of indirect influence of the cellular environments represented by the dynamics of the pop-
ulation numbers B(t) and C(t) (or the respective rates RB, RC) on the tumoral populations quantified
by T (t), J(t). The scheme shown in Fig.1 outlines the topology of interactions and responses of T , J
to the exogenous parameters. Instead of analyzing intuitively obvious anti-proliferative/apoptotic effects
8
controlled by the parameters αC , αB , βC , βB we investigate sensitivity to the components of the tuple
χE = [hCT , gCC , gCB, hBT , gBC , gBB ] , (9)
which parametrize (1 + hCTT )CgCC , BgCB and (1− hBTT )CgBCBgBB . (Here, the lower index E of χE
emphasizes the environmental dependence).
2. The dynamical instability generating tumor growth is induced by the superthreshold choice of the param-
eter gTC (see Table 1). (The parameter appears in the term ∼ CgTCT gTT which constitutes RT .)
3. The constancy of the selected parameters listed in the tuple [Eq. (9)] is no longer considered, but the
continuous in time dependencies will be introduced, where the original parameters are replaced by some
exogenous time-varying functions [see Eq.(13) in the text below]
χ˜E(t, .) =
[
h˜CT (t, .), g˜CC(t, .), g˜CB(t, .), h˜BT (t, .), g˜BC(t, .), g˜BB(t, .)
]
(10)
purposefully constructed to stay in the vicinity of their respective former static values. The proposal of
the specific time dependencies implies the need for additional (discrete) parameters that not only control
the switchover between the base functions but undergo optimization as well. Consequently, the constant
parameters involved in RB, RC are replaced by the corresponding time dependencies, formally
RC(. . . , hCT , gCC , gCB) −→ R˜C(. . . , h˜CT (t, .), g˜CC(t, .), g˜CB(t, .)) , (11)
RB(. . . , hBT , gBC , gBB) −→ R˜B(. . . , h˜BT (t, .), g˜BC(t, .), g˜BB(t, .)) .
4. The inverse formulation is suggested which assumes the construction of the objective function f(.) which
quantifies the degree of undesired behavior of T (t) and J(t). It follows that the aim of the optimization of
f(.) is the selection of Eq.(10) which admits tumor suppression for given time interval.
2.3 Discretization of the parametric space, exogenous symmetric pulses
The sensitivity analysis is based on the optimization of the exogenous stimulation from Eqs.(10), (11) which
must be specified in more detail. In the present form it includes combinations of the auxiliary discrete parameters
forming the strings
s ≡ [sI , shCT , sgCC , sgCB , shBT , sgBC , sgBB ] . (12)
The grid optimization passes through the space of possibilities, where each possibility is encoded by the string
s. Continuity in time is guaranteed since two input pulses of prescribed shapes ΨC(t, sI), ΨB(t) modify the
9
original Eq.(9) in a multiplicative manner as it follows
h˜CT (t, shCT , sI , Q) = hCT ( 1 +QshCT ΨC(t, sI) ) , (13)
g˜CC(t, sgCC , sI , Q) = gCC ( 1 +QsgCCΨC(t, sI) ) ,
g˜CB(t, sgCB , sI , Q) = gCB ( 1 +QsgCBΨC(t, sI) ) ,
h˜BT (t, shBT , Q) = hBT ( 1 +QshBT ΨB(t) ) ,
g˜BC(t, sgBC , Q) = gBC ( 1 +QsgBCΨB(t) ) ,
g˜BB(t, sgBB , Q) = gBB ( 1 +QsgBBΨB(t) ) .
The parameter Q ≥ 0 may be interpreted as the strength of therapeutic action. In the modeling below, we focus
on the possible shapes of multi-dimensional pulse and their responses which can be used to model reversible
variations of individual parameters. For that purpose, the discrete argument sI of ΨC(t, sI) is introduced [see
Eq.(15) and illustrating Fig.2 below] to control timing and width of the pulse. Regarding the focus of our study,
continuous (constant) administration is excluded because of the requirement of dominating autonomous regimes
in the late-time systemic response which is equivalent to the condition of the presence of a rest period that allows
for the recovery from toxicity [48].
The space of pulse configurations is determined by s including the four-state component sI ∈ Ω(4) def=
{0, 1, 2, 3}, and six three-state components sindex ∈ Ω(3) def= {−1, 0, 1}, where index ∈ { hCT , gCC , gCB , hBT ,
gBC , gBB}. Next we will study optimality of the strings
s ∈ Ω def= Ω(4) × Ω(3) × Ω(3) × . . .× Ω(3)︸ ︷︷ ︸
6×
, (14)
where the cardinality card(Ω) = 4× 36 = 2916 possible states.
The functions ΨC(t, sI), ΨB(t) used to carry out the sensitivity testing are modeled by means of the ele-
mentary symmetric pulses
ΨB(t) = ψ(t, t0, ξ0, σ0) , (15)
ΨC(t, sI) = δsI ,0 ψ(t, t0, ξ0, σ0) + δsI ,1 ψ(t, t0, ξ1, σ0)
+ δsI ,2 ψ(t, t1, ξ0, σ0) + δsI ,3 ψ(t, t1, ξ1, σ0) ,
where δsI ,s denotes the Kronecker symbol, which equals to 1 or 0 depending on the match or mismatch status
of sI and one of the referential values from Ω(4). Note that the pulse timing and shaping encoded by sI ∈ Ω(4)
undergo optimization as well. Incorporation of the sequential pulses controlled by sI is inspired by [49].
We remind that the role of the parameter sI is crucial, since it determines the timing and shape of the pulses;
ΨB(.) is not affected by this parameter and serves as referential. For all possible pairs of arguments (t0, ξ0);
(t0, ξ1); (t1, ξ0); (t1, ξ1) including the time-translation ttr ∈ {t0, t1} and time rescaling factors ξsc ∈ {ξ0, ξ1}
we define four child wavelets [see Eq.(15)]
ψ(t, ttr, ξsc, σ0) =
1√
ξsc
φ
(
t− ttr
ξsc
, σ0
)
(16)
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which exploit the continuous-time univariate Gaussian symmetric model
φ(t) = φS(t
′, σ0) = exp
[
−1
2
(
t′
σ0
)2]
, (17)
where σ0 is the pulse width [σ0 < (t1 − t0)].
More realistic (asymmetric) variant of the function φ is introduced and studied in sec. 6. To avoid the direct
impact of the pulses on the boundaries, the times t0, t1 were chosen to guarantee the localization of the pulse
peaks far enough from the boundary values tS and tE , where tE > t1 > t0 > tS , i.e. we assume ψ ∼ 0 for
t ∈ {tS , tE}. The time span tE − tS − 2σ0 corresponds, at the conceptual level, to what is called the "drug
holidays" [50, 51, 48]. Unlike the superposition of Dirac pulses, which define the control function in the above-
cited reference, we have the finite pulse width σ0. Obviously, the symmetry of input signal does not imply of the
population responses. In particular, the unstable tumor growth causes irreversible changes which, in principal,
can not be compensated solely by the action of reversible exogenous factors selected here. To summarize this
section, the auxiliary functions ΨB(.) and ΨC(.) were introduced to construct the reversible exogenous pulses
of dimension six [see Eqs.(13) and (14)].
2.4 Objective function, constrained optimization of tumor response
In this section we focus on the optimization of tumor responses to the parametric environmental factors with the
aim to identify those factors which lead to required changes of the tumoral subpopulations during some interval of
observation. In conformity with the optimization theory, the objectives of indirect parametric and environmental
manipulations with tumoral populations are quantified by the objective function. The proposed formulation
consists of two main components. At first, the optimization component enables us to discriminate between
many alternative therapeutic strategies (and to select, regarding the model, the optimum solution). Secondly,
the component of sensitivity analysis enables more subtle understanding of the relationships between exogenous
inputs and output variables in a system and, in addition, it enables to study degree of sparsity and robustness [51]
of the proposed solutions. To pursue the above aims in our specific case of the model of unstable tumor growth,
several key measures of tumor response are incorporated into the objective function.
2.4.1 The measures of tumor responses, objective functions
Below we introduce the key measures that reflect tumor responses in our specific case of unstable tumor growth.
The time interval for the observation of the systemic dynamics is 〈 tS , tE 〉 (tS stands for the time of start, tE for
the end). Further, we assume that population variations within the interval 〈 tS , tE 〉 do not contribute directly
to the objective functions values that are calculated purely from the population characteristics at the interval
endpoints.
Manipulation with several tumor populations requires multi-objective formulation. As the optimality should
be evaluated not only for T but for J as well, two different objective functions are introduced
fT (tS , tE , s)
def
=
T (tE , s)
T (tS)
, fJ(tS , tE , s)
def
=
J(tE , s)
J(tS)
, (18)
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where the notation emphasizes the conditioning by discrete s. We formulate the objective function in the terms of
relative (instead of absolute) tumor abundances to be able to stabilize non-free tumor equilibria by environmental
moves (e. g. the pulses of therapy). Such formulation of the objective function is in line with the concept of
adaptive therapy [13]. The alternative formulation exists [29] based on the OBs and OCs abundances that aims
to restore their balance disrupted by MM.
Productive and broadly accepted paradigm in the area of the multi-objective optimization is the Wald’s "mini-
max" optimality [52, 53, 54]. The scalarization procedure was designed to solve multi-objective decision-making
problems where the decisions are made on the basis of the worst possible choice. Owing to this, both measures
from Eq.(18) can be incorporated into the single objective function form
f(tS , tE , s)
def
= max{ fT (tS , tE , s), fJ(tS , tE , s) } , (19)
where the optimal string s = smin is defined in the standard way
smin
def
= arg min
s∈Ω
f(tS , tE , s) . (20)
At the moment, we do not incorporate metastatic potential and drug resistance consequent to the JCs [30, 36]
into the model. In the future, an eventual metastatic population derived from the JCs could be incorporated as
the third component of the objective function.
In order to control the number of non-zero s components (+1 corresponds to stimulation, while −1 stands
for inhibition), the optimization task from Eq.(20) is supplemented with the constraint
δ0,shCT + δ0,sgCC + δ0,sgCB + δ0,shBT + δ0,sgBC + δ0,sgBB = n0(s) , (21)
where n0(s) = 0, 1, . . . , 6 is the number of s components that are equal to 0; δsx,sy is the Kronecker symbol.
The variable sI ∈ Ω(4) absents in the l.h.s. of Eq.(21) as it relates only to the timing and width of the pulses
(Eq.(15)).
As up-to-date anticancer therapies are accompanied by the variety of negative or uncertain side effects,
the constraints may represent the elementary quantification of their impacts [48]. When 6 − n0 increases, the
tendency of the system towards more complex response becomes unavoidable. Therefore, because of direct link
between the number of constraints and parametric sparsity, the term 1−(n0/6) may be interpreted as the index of
parametric redundancy [55]. More compact, constraint-free reformulation where adverse effects are quantified
by 1− (n0/6) regularization term is presented in sec. 5.
2.5 Evaluation of the model outputs
The optimum value of the objective function
fmin ≡ fmin(tS , tE) def= min
s∈Ω
f(tS , tE , s) = f(tS , tE , smin) (22)
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enables straightforward quantification of the quality of the optimization outputs. The disparities in the optimiza-
tion of fT and fJ are represented by the measure
Dfmin
def
=
∣∣∣ min
s∈Ω
fT −min
s∈Ω
fJ
∣∣∣ . (23)
In addition, to understand how the choice of the fitness variant affects smin, we introduced the mean Hamming
distance
dH,smin
def
=
1
7
∑
{∀ s components}
1
(
arg min
s∈Ω
fT 6= arg min
s∈Ω
fJ
)
, (24)
where 1(.) is the indicator function of the logical-type argument, which returns one when the argument is True
and zero otherwise. Having defined a per-component distance measure, we consider the normalization factor
1/7.
3 Numerical implementation, symmetric pulses
3.1 Parameter settings
The parameters used in all simulations are consistent with those used by Koenders and Saso [9]. Their values
are listed in Table 1. Additional in our approach are the parameters which define the exogenous dynamics of the
functions ψ(t, ttr, ξsc, σ0), φS(t, σ0) [see Eq.(16) and Eq.(17)] which provide ΨB(t), ΨC(t, sI) [see Eq.(15)]
for given sI ; their values are
t0 = 140 day > tS = 100 day, t0 < t1 = 160 day < tE = 200 day (25)
and the scaling parameters needed for the evaluation of the functions
ξ0 = 1, ξ1 = 0.5 (scaling factors) , σ0 = 7 day (pulse width) . (26)
The pulse width 2σ0 = 14day has been chosen to be roughly consistent with the half-life of MM cells that is
∼ 10− 20 days. The choice tE − tS = 100day was primarily motivated by elsewhere referred average time for
the restoration of the population size towards equilibrium [8, 9]. The importance of this time scale is supported
by the work [28].
The overall dynamics and system responses were obtained by means of the fourth-order Runge Kutta (RK4)
method with the integration step δt = 5× 10−4day ∼ 8.64 sec.
3.1.1 Static equilibrium - stability
Before going into the details of the parameter settings in dynamic approach, we briefly discuss some of the static
results. The approximate population equilibrium B = B(0)eq = 230.87, C = C
(0)
eq = 1.685, T = T
(0)
eq = 9.0
was calculated using Eqs. (3), (4), adopted from [9]. We note that the "zero-order" equilibrium did not take
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param. val. class param. val. class param. val. class
αC = 3.0 day
−1 RC αB = 4.0 day−1 RB αT = 0.3 day−1 RT
αJ = 0.001 day
−1 RJ βC = 0.2day−1 RC βB = 0.02 day−1 RB
βT = 0.1 day
−1 RT βJ = 0.3 day−1 RJ κJ = 0.3 day−1 RT
hBT = 0.035 RB hCT = hBT RC gCC = 0.5 RC
gCB = −0.5 RC gBC = 1.0 RB gBB = 0.0 RB
gTT = 0.5 RT ————– —— gTC,init = 0.0 RT
gTC,stab = 0.3 RT gTC,thr = 0.3648 RT gTC,unstab = 0.37 RT
Table 1: The constant model parameters used in all simulations. The parameter values (param. val.) are adopted
from the work [9]. They are divided into four classes - four rates,RC , RB, RT , RJ according to the occurrence on
the right hand side of Eq.(2). The underlined parameters hBT , . . . , gTT are later replaced by their corresponding
time-varying analogs [see Eq.(13)]. Four variants of the parameter gTC (bottom rows of the table) were used to
simulate the stability/instability of steady states in the tumor growth context.
into account population of the JCs (J = 0). In addition, the approximation assumed gTC = gTC,init = 0.0.
By using asymptotes of direct integration of Eqs.(1) and (2) for appropriately chosen nonzero constant value
gTC = gTC,stab = 0.3, the previous equilibrium estimates changed and the asymptotically stable equilibrium
B
(1)
eq = 211.42, C
(1)
eq = 2.052, T
(1)
eq = 13.854, J
(1)
eq = 0.0947 was obtained.
3.2 Initiation, imbalance, pathogenesis and MM progression
Our modeling of initiation and promotion of MM pathogenesis takes into account early steps of OCs involve-
ment in that process. According to [56], the direct interactions between MM cells and OCs may increase MM
proliferation which is mediated by ∼ CgTCT gTT term. Therefore, we assume that the large pathogenic irre-
versible changes can be modeled with increased gTC which causes unstable growth of the populations of MM
cells. The parametric shift in gTC exceeding gTC,stab results in the permanent instability that may be attributed to
the abnormal cell signaling, modulation of microenvironment, or dysregulation that irreversibly degrades bone.
From the point of view of the evolutionary game theory [26], the shift can be attributed to the perturbation of
OC-MM coexistence line. A more microscopic interpretation can be found in [57, 29], where the MM growth is
stimulated by OCs secretion of TNFα cytokine.
We have numerically found that the parameter gTC reveals the threshold value gTC,thr ' 0.3648 which
separates the stable equilibrium from the unstable regime. Consequently, the supercritical value gTC,unstab =
0.37 > gTC,thr was used in the tumor growth simulations. The unstable system is integrated over the initial
tS = 100day with constant parameters, i. e. for Q = 0. This period is used to simulate the uncontrolled
growth. The resulting values T (tS) = 16.784 and J(tS) = 0.132 have been stored for later comparative
purposes. After this period, the tumor suppression is purposefully initialized. Subsequently, the equations were
integrated for the time interval 〈tS , tE〉, where tE = 200 day. The pairs (T (tS), T (tE)), (J(tS), J(tE)) were
used to calculate the objective function defined by Eq.(18). In the case Q = 0 (without pulses), when there is
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no dependence on s (total degeneracy) and, consequently, no optimization is possible, the calculation provides
f = fJ = 1.1568 > fT = 1.0681. This result suggests that, at least in the lowQ region, more rapidly expanding
population of the JCs could be suppressed with higher priority [in the light of the criterion specified in Eq.(19).
3.3 Results, symmetric pulses
Before presenting the simulation results, we visualize examples of the elementary Gaussian exogenous pulses
[see Eq.(15), Fig.2] for different sI . Next, instead of immediate quest for the optimality, we find instructive
to inspect the entire search space. Our findings (see Fig. 3) demonstrate that not all the strings s ∈ Ω are
tumor suppressive, i. e. providing f(.) < 1. It seems that the outputs quantified by f(.) split into qualitatively
different branches. One may identify the options s ∈ Ω corresponding to the quasi-equilibrium (line f = 1),
unstable tumor growth (f > 1), or temporary tumor suppression (f < 1), respectively. It can be seen that for
too small Q the desired effects (f < 1) can not be achieved, and growth instability may be suppressed only
for Q > Qthr = 0.049. It demonstrates that the parametrization covers a broad range of scenarios, so that
optimization can affect the therapeutic efficiency.
After illustrating all the possible scenarios contained in Ω, we turn to the analysis of the optimal selections
(see Fig.4). It seems that the small and large Q regions differ in qualitative as well as quantitative components.
The complex form of fmin(Q) consisting of several sharp folds arises at large Q. This is because of combined
effect of discretization, selection, and nonlinearities, as well as the strength of exogenous factors. With increasing
n0, the sharp irregular folds in the fmin(Q) dependencies become smoother (see Fig.4). Such lowered sensitivity
to Q arises due to very restrictive constraints (constructed for high n0) corresponding to the limited number of
parameters with lowered sensitivity to Q. In Fig.5 we see how the invasiveness of the MM and JCs varies with
Q. The characteristics Dfmin(Q) shows V-shaped (n0-dependent) minima that reflect the compensatory effect
of fT and fJ localized slightly above the threshold values Qthr(n0).
For further details, we refer the interested reader to Appendix, which contains discussion of the periodic
extensions of the solutions obtained as well as the stability of the RK4 method and its comparison with the
implicit integration methods, regarding specific aspects of our application.
The results of constrained optimization with n0 = 0 are presented in Tab. 2. Similarly, the systematic
analysis covers n0 = 1 (see Tab. 3), n0 = 2 (Tab. 4), n0 = 3 (Tab. 5), n0 = 4 (Tab. 6). This demonstrates that
the optimized components of smin are interdependent. In fact, these outputs, apart from underlying complexity
of the responses, answer the questions about the parametric sensitivity in the particular regions of (Q,n0) plane.
Apparently, the components of smin differ not only in the persistence of the prevailing discrete values, but in
the tendencies to make jumps along the Q coordinate as well. The complexity of the smin(Q,n0) emerges from
the nonlinearity which destabilizes the form of exogenous pulses. As the available options for the exogenous
influence narrow down with n0, the relative influence of certain parameters becomes more apparent.
Although a detailed interpretation of the structure of smin strings may be difficult, a few instructive facts
outline their implicit logic. Some of the results are relatively robust to the specific assumptions, including the
choice of Q or n0. To illustrate this, we reconsider the solution smin = [3,−1,−1,+1,−1, +1,−1] obtained
for n0 = 0, Q ∈ 〈0.01, 0.27〉 (Tab. 2, Tab. 3). This string shows essential overlap with that of the neighboring
interval Q ∈ 〈0.27, 0.63〉. The only difference is in the sensitivity of the third component (sgCC = +1) →
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(sgCC = −1). Interestingly, the same component destabilizes [(sgCC = −1)→ (sgCC = 0)] when the constraint
n0 = 1 is applied. In addition, we see that the therapy applied to the both feedback components, shCT = −1 and
shBT = −1, acts against the tumor influence on OCs and OBs. This is in line with autocrine inhibition of OCs by
sgCC = −1 which may reduce replication rate of the tumoral cells ∼ αTCgTCT gTT . More universal perspective
can be captured from the comparison in Tabs. 2-5. Here, the highest stability is achieved for shBT = −1 and
sgBC = +1, while sgCB is very sensitive to Q. However, as shown in Tabs. 6-7, the role of sgCB is unique, as its
nonzero values are robust against selection imposed by the constraints with n0 ≥ 4. In this case, the zero values
of shCT , sgCC shBT , sgBB are quite persistent with respect to Q. Within the resulting optimal sparse solution, the
effect of therapeutically relevant timing is controlled by sI coupled with sgCB = +1 and sgBC = −1.
inter. length
× 100
Q
interval sI shCT sgCC sgCB shBT sgBC sgBB
26 < 0.01, 0.27 > 3 - - + - + -
36 < 0.27, 0.63 > 3 - + + - + -
12 < 0.63, 0.75 > 0 - + - - + -
8 < 0.75, 0.83 > 1 - + - - + -
42 < 0.83, 1.25 > 0 + - - - + -
3 < 1.25, 1.28 > 1 + - - - + -
58 < 1.28, 1.86 > 0 - - - - + -
13 < 1.86, 1.99 > 1 - - - - + -
30 < 1.99, 2.29 > 3 - + + - + -
102 < 2.29, 3.31 > 1 - + + - - -
168 < 3.31, 4.99 > 1 - - + - - -
Table 2: The results of constrained optimization with n0 = 0. The relations between Q and smin remain
persistent for given intervals of Q (i.e. for the respective line of the table). The lengths of the Q intervals
are given in the first column. The columns sI , shCT , . . . , sgBB correspond to the optimum smin. The notation
− ≡ −1, + ≡ 1 is used here as well as for all the tables with the similar structure.
4 Alternative scalarizations: linkage between the worst-case and the best-case
In this section we address the particular issue how the optimization output depends on the particular scalarization
of the original multi-objective problem considering the objectives fT and fJ , which further opens the question
of the stability of the optima. For a stable scalarization, the small variation in the original formula results in
the small change in the optimum obtained. To investigate the issue of eventual alternatives to the benchmark
scalarization by the worst-case scenario, we propose the following framework requirements: (a) the alternative
scalarization is parametrized by the single real parameter which quantifies deviation from the worst-case limit;
(b) the invariance under the exchange of fT and fJ ; (c) scalarizations proceed from the generalized mean that
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inter. length
× 100
Q
interval sI shCT sgCC sgCB shBT sgBC sgBB
25 <0.01, 0.26> 3 - - + - + 0
< 1 <0.27, 0.27> 3 - 0 + - + -
35 <0.28, 0.63> 3 - + + - + 0
6 <0.64, 0.70> 0 - + - - + 0
14 <0.71, 0.85> 0 + 0 - - + -
20 <0.86, 1.06> 0 - 0 - - + -
8 <1.07, 1.15> 0 + - - - + 0
18 <1.16, 1.34> 0 0 - - - + -
28 <1.35, 1.63> 0 - - - - + 0
92 <1.64, 2.56> 0 + + 0 - + -
44 <2.57, 3.01> 1 + + 0 - + -
80 <3.02, 3.82> 1 - 0 + - - -
19 <3.83, 4.02> 1 - - + - - 0
< 1 <4.03, 4.03> 1 - - 0 - - -
95 <4.04, 4.99> 1 - - + - - 0
Table 3: The results of the f(tS , tE , s) minimization constrained by n0 = 1. The differences in smin obtained
for different intervals of Q. Total persistence of the shBT = −1. Relatively high persistence of sgBC = 1 for
Q < 3 (See results of synergistic analysis in sec.6.2 below). Highest number of zeros and highest frequency of
the changes between −1 and 0 is shown in the column sgBB .
expresses the central tendencies of fT and fJ . The alternative which fulfills the above requirements is Lehmer
mean [42]
fL(pL) =
fpLT + f
pL
J
fpL−1T + f
pL−1
J
(27)
which we use in the further analysis. The family of scalarized variants {fL(pL) | pL ∈ R} uses pL to bridge
the worst-case fL(pL → ∞) = max{fT , fJ} and the best-case fL(pL → −∞) = min{fT , fJ} (therapeuti-
cally infeasible) limits. To quantify the level of stability, the global optimum sL,min = arg mins∈Ω fL(pL) is
compared with the optimum corresponding to the worst-case limit via the alternative mean Hamming distance
dL,smin(pL) =
1
7
∑
{∀ s components}
1
(
arg min
s∈Ω
fL(pL) 6= arg min
s∈Ω
f
)
. (28)
constructed in complete analogy to Eq.(24). The results of the numerical analysis of dL,smin corresponding to
the case n0 = 0 (other constraints show an analogous behavior) are presented in Fig.6. They confirm qualitative
differences between negative (unstable, i.e. considerably different from the worst-case), and stable domains
of sufficiently large pL > 0. The additional information obtained from the calculations is that scalarizations
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inter. length
× 100
Q
interval sI shCT sgCC sgCB shBT sgBC sgBB
4 <0.01, 0.05> 3 0 - + - + 0
42 <0.06, 0.48> 3 - 0 + - + 0
13 <0.49, 0.62> 3 0 + + - + 0
15 <0.63, 0.78> 0 + 0 - - + 0
10 <0.79, 0.89> 0 0 0 - - + -
17 <0.90, 1.07> 0 - 0 - - + 0
2 <1.08, 1.10> 1 - 0 - - + 0
23 <1.11, 1.34> 0 0 - - - + 0
12 <1.35, 1.47> 1 0 - - - + 0
108 <1.48, 2.56> 0 + + 0 - + 0
44 <2.57, 3.01> 1 + + 0 - + 0
100 <3.02, 4.02> 1 - 0 + - - 0
0 <4.03, 4.03> 1 - - 0 - - 0
95 <4.04, 4.99> 1 - 0 + - - 0
Table 4: The optimized components of smin (see Eq.(20)) obtained for the constraint n0 = 2 (see Eq.(21)).
performed for the small Q region (approximately Q . 0.2) are relatively well stabilized. This contrasts with
the optimal sL,min corresponding to the higher Q values, where sensitivity to pL becomes pronounced. We see
that computational (and, eventually, therapeutic) problems lie mainly in the domain of high Q values, where the
irregular and less persistent behavior of dL,smin(pL) can be observed.
5 Modified objective function with the penalty term, sparse optimization
We completed our work by experimenting with the alternative worst-case scalarized objective function
f(tS , tE , s, λ) = max{ fT (tS , tE , s), fJ(tS , tE , s)}+ λQ
(
1− n0(s)
6
)
, (29)
supplemented by the extra penalty term λQ(1− n0(s)/6) aimed at the selection of representative parameters
[47]. The side effects of the therapy are proportional to the regularization parameter λ ≥ 0 and previously
introduced strength of the therapeutic action Q. The factor (1 − n0(s)/6) ∈ (0, 1) accounts for the fraction
of nonzero s components. To sum up, comparing it to the function f(tS , tE , s) Eq.(19), the above formulation
minimizes unpredictable toxic side effects of the therapy [48] by preferring weaker interventions. Moreover,
strict constraint on s no longer applies. In addition, we note that the sparsity-inducing penalization introduced
by Eq.(29) is analogous to that adopted when considering the effective Markowitz portfolio diversification [58].
In Fig.7 we present numerical results obtained for the function Eq.(29). They reveal that the optimum of
f(tS , tE , s, λ) exists not only in s, but along Q for large enough λ (λ > 0.3) as well. Highly inefficient effects
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inter. length
× 100
Q
interval sI shCT sgCC sgCB shBT sgBC sgBB
<1 <0.01, 0.01> 3 0 - + - 0 0
59 <0.02, 0.61> 3 0 0 + - + 0
31 <0.62, 0.93> 0 0 0 - - + 0
25 <0.94, 1.19> 1 0 0 - - + 0
26 <1.20, 1.46> 3 0 0 + - + 0
141 <1.47, 2.88> 0 0 + 0 - + 0
210 <2.89, 4.99> 1 0 0 + - - 0
Table 5: The effect of the constraint n0 = 3.
inter. length
× 100
Q
interval sI shCT sgCC sgCB shBT sgBC sgBB
169 <0.01, 1.70> 3 0 0 + - 0 0
35 <1.71, 2.06> 0 0 + 0 0 + 0
44 <2.07, 2.52> 1 0 0 + 0 - 0
247 <2.53, 4.99> 1 0 0 + 0 - 0
Table 6: The optimized smin obtained for n0 = 4. Compared to the low n0, longer intervals in Q occur.
correspond to Q & 0.8. As expected [Fig.7(b)], in all the studied cases increase in Q reduces the number of
non-zero elements proportional to 1− (1/6)(n0)min where (n0)min = n0(smin).
6 The case of asymmetric pulses
The symmetric pulses [see Eq.(17)] have been originally designed as a tool of the sensitivity analysis with unclear
relationship to pharmacological applications. Because the pharmacologic characteristics of the pulse protocols
[59] exhibit, in general, non symmetric, right tailed shape in time, we introduce more realistic asymmetric model
in this section. By focusing on the exogenous changes, the model is introduced in two main steps. The first is
inter. length
× 100
Q
interval sI shCT sgCC sgCB shBT sgBC sgBB
498 <0.01,4.99> 3 0 0 + 0 0 0
Table 7: The optimization result for n0 = 5 emphasizing the key role of sgCB .
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represented by the auxiliary formula
φa(t
′, σa,Wa, τa) = exp
[
−(t
′)2
2σ2a
(
1− logist
(
t′
Wa
))
− t
′
τa
logist
(
t′
Wa
)]
(30)
incorporating the logistic function logist(ζ) = 1/(1 + exp(−ζ)) ∈ (0, 1) of the dimensionless argument ζ =
t′/Wa, rescaling the time argument by the transition interval width Wa. The logistic local in time weighting
causes that the characteristic time scale of the infusion/absorption regime 1/σa is smoothly changing (on the
time scale 1/Wa) to the late-time exponential drug elimination/excretion (depending on the metabolic conditions)
with the characteristic time τa.
The second step of the pulse definition reflects the fact that the impact of the drug depends not only on its
concentration but on the effectiveness of the binding on the respective receptor as well, and it may be described
by the transformation
φA(t
′) ≡ φA(t′, kE , σa,Wa, τa) = nE φa(t
′, σa,Wa, τa)
kE + φa(t′, σa,Wa, τa)
(31)
corresponding to the sigmoid model [59]. The form Eq.(31) replaces Eq.(17); nE is the normalization parameter
derived from the condition
∫∞
−∞ dt φS(t, σ0) =
∫∞
−∞ dt φA(t, .). The normalization is proposed to achieve
equivalence between the Gaussian (σ0 = 7day) and the asymmetric pulses defined by kE , σa, Wa, τa. In
the normalized case shorter duration is accompanied with enhanced intensity and vice versa. Two variants of
the parameter kE ∈ {0.1, 1} controlling the drug efficiency have been used in the numerical calculations: (a)
kE = 1 corresponding to the high efficiency regime with normalization prefactor nE = 1.46355; (b) kE = 0.1
as a model of low drug efficiency with nE = 0.44288. In Fig.8, the shape of asymmetric pulses is calculated for
the numerical parameters Wa = 2 day, σa = 3 day, τa = 14 day that we used in further optimizations.
The detailed comparison of the optimization results obtained for the symmetric and asymmetric pulses for
the respective penalty functions [Eq.(29)] with the regularization parameters λ ∈ {0, 0.2, 0.4, 0.6, 0.8, 1} is
presented in Tab. 8. In general, we conclude that (a) the pulse shape affects the optimization result, nevertheless
the correlation of the optimal strings corresponding to the symmetric and asymmetric pulses is positive; (b)
the values of sI encoding the pulse width are more susceptible to the pulse symmetry/asymmetry and drug
efficiency (kE); (c) the nonzero value of sgBB may disrupt the optimization results; (d) the value of sgBC is
relatively persistent for different λ which coincides with its integral synergistic effect identified in sec.6.2.
(A) λ = 0
Pulse kE Q fmin(λ) sI shCT sgCC sgCB shBT sgBC sgBB dH,A−G
asym.L 0.1 0.2 0.7898 2∗ - - + - + - 1
asym.H 1.0 0.2 0.7792 2∗ - - + - 1 - 1
Gauss 0.2 0.8200 3 - - + - + -
asym.L 0.1 0.4 0.6246 2∗ - -∗ • + - + - 2 (1)
asym.H 1.0 0.4 0.6105 2∗ - + + - + - 1
Gauss 0.4 0.6667 3 - + + - + -
asym.L 0.1 0.6 0.4892 2∗ - + + - + - 1
asym.H 1.0 0.6 0.4637 2∗ - + + - + - 1
Gauss 0.6 0.5492 3 - + + - + -
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asym.L 0.1 0.8 0.3734 2∗ • -∗ + ∗ - + - 3 (1)
asym.H 1.0 0.8 0.3513 3∗ -∗ + ∗ - + - 3
Gauss 0.8 0.3395 0 0 0 - - + -
asym.L 0.1 1.0 0.2812 2∗ • - +∗ +∗ - + - 3 (1)
asym.H 1.0 1.0 0.2650 3∗ - +∗ +∗ - + - 3
Gauss 1.0 0.2488 0 - 0 - - + -
(B) λ = 0.2
asym.H 0.1 0.2 0.8231 2∗ - -∗ + - + 0 2
asym.L 1.0 0.2 0.8125 2∗ - -∗ + - + 0 2
Gauss 0.2 0.8512 3 - 0 + - + 0
asym.L 0.1 0.4 0.6820 2∗ - 0 1 - + 0 1
asym.H 1.0 0.4 0.6662 2∗ - 0 1 - + 0 1
Gauss 0.4 0.7310 3 - 0 1 - + 0
asym.L 0.1 0.6 0.5828 2∗ -∗ 0∗ • + - + 0 3 (1)
asym.H 1.0 0.6 0.5637 2∗ -∗ + + - + 0 2
Gauss 0.6 0.6451 3 0 + + - + 0
asym.L 0.1 0.8 0.5050 2∗ -∗ • +∗ +∗ - 0∗ • 0 5 (2)
asym.H 1.0 0.8 0.4810 2∗ 0 +∗ +∗ - + 0 3
Gauss 0.8 0.4195 0 0 0 - - + 0
asym.L 0.1 1.0 0.4362 2∗ • 0 +∗ +∗ - 0∗ • 0 4 (2)
asym.H 1.0 1.0 0.4165 3∗ 0 +∗ +∗ - + 0 3
Gauss 1.0 0.3796 1 0 0 - - + 0
(C) λ = 0.4
asym.L 0.1 0.2 0.8560 2∗ - -∗ • + - 0∗ • 0 3 (2)
asym.H 1.0 0.2 0.8434 2∗ - 0 + - + 0 1
Gauss 0.2 0.8778 3 - 0 + - + 0
asym.L 0.1 0.4 0.7273 2∗ -∗ • 0 + - 0∗ • 0 3 (2)
asym.H 1.0 0.4 0.7176 2∗ 0 0 + - + 0 1
Gauss 0.4 0.7744 3 0 0 + - + 0
asym.L 0.1 0.6 0.6334 2∗ 0 0 + - 0∗ 0 2
asym.H 1.0 0.6 0.6261 2∗ 0 0 + - 0∗ 0 2
Gauss 0.6 0.7104 3 0 0 + - + 0
asym.L 0.1 0.8 0.5624 2∗ • 0 0 +∗ 0∗ • 0∗ 0 4 (2)
asym.H 1.0 0.8 0.5612 3∗ 0 0 +∗ - 0∗ 0 3
Gauss 0.8 0.4995 0 0 0 - - + 0
asym.L 0.1 1.0 0.5017 2∗ • 0 0 +∗ 0∗ 0∗ 0 4 (1)
asym.H 1.0 1.0 0.5144 3∗ 0 0 +∗ 0∗ 0∗ 0 4
Gauss 1.0 0.4796 1 0 0 - - + 0
(D) λ = 0.6
Pulse kE Q fmin(λ) sI shCT sgCC sgCB shBT sgBC sgBB dH,A−G
asym.L 0.1 0.2 0.8776 2∗ -∗ 0 + - 0∗ 0 3
asym.H 1.0 0.2 0.8669 2∗ -∗ 0 + - 0∗ 0 3
Gauss 0.2 0.8996 3 0 0 + - + 0
asym.L 0.1 0.4 0.7560 2∗ 0 0 + - 0 0 1
asym.H 1.0 0.4 0.7453 2∗ 0 0 + - 0 0 1
Gauss 0.4 0.8128 3 0 0 + - 0 0
asym.L 0.1 0.6 0.6609 2∗ 0 0 + 0∗ 0 0 2
asym.H 1.0 0.6 0.6624 2∗ 0 0 + 0∗ 0 0 2
Gauss 0.6 0.7623 3 0 0 + - 0 0
asym.L 0.1 0.8 0.5891 2∗ • 0 0 +∗ 0∗ 0∗ 0 4 (1)
asym.H 1.0 0.8 0.5966 3∗ 0 0 +∗ 0∗ 0∗ 0 4
Gauss 0.8 0.5795 0 0 0 - - + 0
asym.L 0.1 1.0 0.5350 2∗ • 0 0 +∗ 0∗ 0∗ 0 4 (1)
asym.H 1.0 1.0 0.5477 3∗ 0 0 +∗ 0∗ 0∗ 0 4
Gauss 1.0 0.5796 1 0 0 - - + 0
(E) λ = 0.8
asym.L 0.1 0.2 0.8922 2∗ 0 0 + - 0 0 1
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asym.H 1.0 0.2 0.8814 2∗ 0 0 + - 0 0 1
Gauss 0.2 0.9148 3 0 0 + - 0 0
asym.L 0.1 0.4 0.7701 2∗ 0 0 + 0 0 0 1
asym.H 1.0 0.4 0.7653 2∗ 0 0 + 0 0 0 1
Gauss 0.4 0.8394 3 0 0 + - 0 0
asym.L 0.1 0.6 0.6809 2∗ 0 0 + 0 0 0 1
asym.H 1.0 0.6 0.6824 2∗ 0 0 + 0 0 0 1
Gauss 0.6 0.7926 3 0 0 + 0 0 0
asym.L 0.1 0.8 0.6158 2∗ • 0 0 +∗ 0∗ 0∗ 0 4 (1)
asym.H 1.0 0.8 0.6232 3∗ 0 0 +∗ 0∗ 0∗ 0 4
Gauss 0.8 0.6595 0 0 0 - - + 0
asym.L 0.1 1.0 0.5684 2∗ • 0 0 +∗ 0∗ 0 0 3 (1)
asym.H 1.0 1.0 0.5810 3∗ 0 0 +∗ 0∗ 0 0 3
Gauss 1.0 0.6796 1 0 0 - - + 0
(F) λ = 1.0
asym.L 0.1 0.2 0.9000 2∗ 0 0 + 0∗ 0 0 2
asym.H 1.0 0.2 0.8922 2∗ 0 0 + 0∗ 0 0 2
Gauss 0.2 0.9282 3 0 0 + - 0 0
asym.L 0.1 0.4 0.7834 2∗ 0 0 + 0 0 0 1
asym.H 1.0 0.4 0.7786 2∗ 0 0 + 0 0 0 1
Gauss 0.4 0.8543 3 0 0 + 0 0 0
asym.L 0.1 0.6 0.7009 2∗ 0 0 + 0 0 0 1
asym.H 1.0 0.6 0.7024 2∗ 0 0 + 0 0 0 1
Gauss 0.6 0.8126 3 0 0 + 0 0 0
asym.L 0.1 0.8 0.6424 2∗ • 0 0 ∗ 0∗ 0∗ 0 4 (1)
asym.H 1.0 0.8 0.6499 3∗ 0 0 ∗ 0∗ 0∗ 0 4
Gauss 0.8 0.7395 0 0 0 - - + 0
asym.L 0.1 1.0 0.6017 2∗ • 0 0 +∗ 0∗ 0∗ 0 4 (1)
asym.H 1.0 1.0 0.6144 3∗ 0 0 +∗ 0∗ 0∗ 0 4
Gauss 1.0 0.7796 1 0 0 - - + 0
Table 8: Comparison of the optimized results for the asymmetric and
Gaussian pulses for different parameters of efficiency (kE), regu-
larization (λ) and the strength of therapeutic action (Q). Star sym-
bol is used for the features - components of smin where the optimal
solutions are different for symmetrical (line denoted as Gauss) or
non-symmetrical (line denoted as "asym.") pulses. The rightmost
column informs about the Hamming distance dH,A−G between the
optimal configurations corresponding to the asymmetric or sym-
metric pulses, respectively (distance is equal to the total number
of the star symbols within the line). In addition, the number in
the parenthesis (included only for nonzero values) represents the
Hamming distance between the asymmetric configurations.
6.1 From discrete to continuous optimization on branched manifolds
In this section we present two illustrative examples of the application of the hybrid optimization procedure which
demonstrates significance of the consecutive corrections to the original discrete problem. The modification shows
that the progress in the optimization is inseparable from the additional constraints and parametrizations.
The original settings given by Eq.(13) can be modified by means of newly introduced auxiliary six "weight"
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variables
h˜CT = hCT (1 + qhCTQhCT shCTψC) , g˜CC = gCC(1 + qgCCQgCCsgCCψC) , (32)
g˜CB = gCB(1 + qgCBQgCBsgCBψC) , h˜BT = hBT (1 + qhBTQhBT shBTψB) ,
g˜BC = gBC(1 + qgBCQgBCsgBCψB) , g˜BB = gBB(1 + qgBBQgBBsgBBψB) .
In order to preserve the original meaning of the unique scalar amplitude Q, the impact of optimization is redis-
tributed on the non-uniform weights which satisfy constraint Tr(q) = qhCT +qgCC+qgCB+qhBT +qgBC+qgBB =
6, q• > qground > 0. The weighting is reflected by the modified penalty term λQq ·s = λQ(qhCT shCT +qgCCsgCC
+qgCBsgCB +qhBT shBT +qgBCsgBC +qgBBsgBB ). The optimization constraints which delimit q components
can be satisfied by considering specific parametrization. It can be represented by the one-dimensional manifold
M1 ≡ {s ∈ Ω,q(η) ∈ R6, η ∈ (0, 1) ⊂ R} with the branches
qhCT (η) = qground + (1− qground)6η5 , (33)
qgCC (η) = qground + (1− qground)30η4(1− η) ,
qgCB (η) = qground + (1− qground)60η3(1− η)2 ,
qhBT (η) = qground + (1− qground)60η2(1− η)3 ,
qgBC (η) = qground + (1− qground)30η(1− η)4
qgBB (η) = qground + (1− qground)6(1− η)5
parametrized by the auxiliary real variable η ∈ 〈0, 1〉 and constant qground ∈ 〈0, 1〉. We note, for later comparisons,
that former discrete optimization corresponding to the uniform weighting q• = 1 performed for the asymmetric
pulses and kE = 1, Q = 0.4, λ = 0.2 leads to smin = [2,−1, 0, 1,−1, 1, 0] corresponding to fmin = 0.666259.
Extending the search space on M1 parametrized by qground = 0.2, using the Ridders’ variant of Dekker-Brent
method [60] applied to dimension η ∈ 〈0, 1〉 leads to the modified sM1min = [2,−1, 1, 1,−1, 1, 0] but lower
fM1min = 0.5266 obtained for η
M1
min ' 0.583. In such case, the highest optimal weight qM1gCB ,min ' 1.85 is posed
on the OC-OB interaction term while the lowest weight qM1gBB ,min = 0.2605 loses its meaning by being present
simultaneously with the multiplier sM1gBB ,min = 0.
It should be emphasized that the highest weight is consistent with the central role of sM1gCB in coincidence
with the findings of the synergistic concept (see sec.6.2). As there is no smooth transition to the uniform weight-
ing for M1, qground < 1, we introduce the alternative manifold M2 by qM2(η) ≡ qground[1, 1, 1, 1, 1, 1] + (1 −
qground) 6[1, η, η
2, η3, η4, η5]/(1 + η + η2 + η3 + η4 + η5) to reach qM2• = 1 in the limit η
M2
min = η → 1. How-
ever, in this case the optimization routine has determined relatively shallow fM2min = 0.6608 corresponding to
the string sM2min = [2,−1, 0, 1,−1, 1, 0] accompanied by ηM2min = 0.86 and weights qM2min ' [1.30, 1.15, 1.03,
0.92, 0.83, 0.75].
6.2 Synergistic quantification of optimization results
The optimization task that we studied clearly demonstrates that the parameters do not act independently to each
other and the optimum depends on the simultaneous effect of the parametric combination. In the next, we
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put the multi-parametric optimization outputs into the context of existing synergistic concepts as conceived in
the biomedical and farmacological studies of the simultaneous effects of therapeutic drugs (see e.g. [61, 62]).
Despite many alternative measures and approaches have been already proposed, the synergistic quantification of
the optimization outputs is not straightforward. The generalization we made is inspired by the form of classic
Loewe’s additivity principle [63].
Before performing quantification of the optimization of the parametric pairs, we introduce reduced string sˆ
with the six enumerated components sˆ1 = shCT , sˆ2 = sgCC , sˆ3 = sgCB , sˆ4 = shBT , sˆ5 = sgBC , sˆ6 = sgBB .
They allow to construct the sets of pairs Ωˆij = { {sˆi, sˆj} ; sˆk = 0 ∀k 6= i, ∀k 6= j}. The extraordinary sI (its
zero value does not mean the absence of the pulse influence) is excluded from the enumeration, nevertheless,
its optimization effect is considered as well; see Eq.(35) below. Selection of Ωˆij is consistent with the fact that
pairwise synergy makes sense only for nonzero pairs sˆi, sˆj . The corresponding scalar measures may be arranged
into 6× 6 matrix of the generalized combination indices
CIfij =
fˆmin, ij
2fˆmin, ii
+
fˆmin, ij
2fˆmin, jj
= fˆmin, ij
(
2fˆmin, iifˆmin, jj
fˆmin, ii + fˆmin, jj
)−1
︸ ︷︷ ︸
harmonic mean
, (34)
where
fˆmin, ij = min
{sˆi, sˆj} ∈ Ωˆij , sI ∈ Ω(4)
f(. . .) . (35)
Here, the single parameter effects are involved in the diagonal elements fˆmin, ii, fˆmin, jj , while the cumulative
effects of the pairs are included in fˆmin,ij . There is an obvious freedom of the choice of the prefactor [see
Eq.(34)], however, as one may check, only the multiplication of both summands by 1/2 leads to the harmonic
mean normalization of fˆmin,ij .
The properties CIfij = CIfji, ∀i, j (symmetry); CIfii = 1, ∀i (unit diagonal as a referential value
corresponding to monoparametric effects); CIfij > 0 [implicated by f(. . .) > 0] CIfij ≤ 1 ∀i, j can be
checked easily. At this point, it is also important to note the basic difference between the effects of monotherapy
and the effects caused by the optimization of individual parameters. In agreement with the original conception
of the combination index, lower index value means higher synergy of the parametric pair.
To avoid detailed comparison of the pairs, we turn to the information comprised in ICf ′i = (1/5)
∑6
j=1;j 6=i ICfij .
In the correspondence with the standard Loewe’s formulation, the higher the synergy, the lower CIfij (or CIf ′i)
is obtained. The results of the numerical calculations of the six components of ICf ′i(Q) are depicted in Fig.9.
They uncover the highest cumulative synergistic effect of sˆ3 = sgCB with another parameters. The identification
of the central role of sgCB in the optimization process is in the qualitative agreement with Table 8, where the
nonzero sgCB persists up to the high λ > 0 considered.
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7 Conceptual model, indirect environmental manipulation
The key aspect of our approach is the formal separation of the system into the environmental and cancerous
compartments (populations), as well as the identification of the parameters appropriate for indirect environmen-
tal therapeutic manipulation. Specific information contained in the results delivered exclusively by simulations
is hardly transferable between alternative models. The transmission can be facilitated by the generalization ob-
tained by filtering, comparative analysis and synthesis of some particular information contained in the population
models.
The way how to do it is the conceptualization based on general and abstract dynamic system for the pair
of the population vectors (T (t), E(t)), where T (t) describes the tumoral and E(t) environmental dynamics,
respectively. The parametric selection is involved in the constant tuple χE (see Eq.(9) as particular example).
Then, the pair of the corresponding rate functions [RT (T ,E[χE ]),RE(T ,E[χE ])] characterizes the original
autonomous ODEs system
d
dt
( T
E
)
=
( RT (T ,E[χE ])
RE(T ,E[χE ])
)
. (36)
The exogenous variant of ODEs system belongs to the respective substitutions χE → χ˜E(t, s), E[χE ] →
E[χ˜E(t, s)], RX(T ,E[χE ]) → R˜X(T ,E[χ˜E(t, s)]) for s ∈ Ω (see Eq.(10)) and X ∈ {T ,E}. Formally, the
solutions [T (t, s,Tinit,Einit), E(t, s,Tinit,Einit)] for given initial condition [T (tinit), E(tinit)] ≡ [Tinit,Einit]
with tinit ≤ tS can be obtained. Subsequently, the adverse effects of the tumoral dynamics along the path
segment
PT ,E(tS , tE , s) ≡ { [T (t, s,Tinit,Einit),E(t, s,Tinit,Einit)] , ∀t ∈ 〈tS , tE〉 } (37)
are quantifiable by the objective function
f(tS , tE , s) = F{PT ,E(tS , tE , s)} , (38)
where F{.} stands for some real-valued functional. In particular cases, that we have already discussed (see
Eq.(18)), the special emphasis has been placed on the boundary interval values. Again, as in the case of specific
formulation in sec.2, the optimal therapy smin is determined by Eq.(20).
8 Conclusion
In this article we present a global strategy that combines sensitivity analysis and global optimization approach
which contrasts with the single parameter (local) investigations. As an intriguing aspect of our holistic view
we see the synthesis of several different research directions. Substantial nonlinearity of ODE system is studied
using multi-parametric pulses of symmetric and asymmetric form. In general terms, our approach provides
a mapping between continuous problem formulated as ODEs and discrete problem where the ordering of the
solutions according to the values of the respective objective function matters. Apart from the optimal therapeutic
procedure itself, we are interested in the analysis of the sensitivity of differential equation systems to the complex
parametric changes to which the potential therapies can be targeted. The results support potential benefits of
our approach not only for monotherapies but also for the combined treatments. By incorporating synergistic
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measures of the parametric pairs, progress has been made in the model-level understanding of the complex
systemic responses to the multi-dimensional pulses. It seems that many models of biological systems could be
studied in a similar way regardless of the area of application. From a biological/pharmacological point of view,
we do not follow conventional line of direct elimination of cancer cells; instead, more emphasis is given to the
indirect effect achieved by the optimized manipulation with the tumoral environment. In addition, we point out
that the results of our discrete combinatorial approach reveal many possible alternatives of restoring the balance
between myeloma and the environment, as opposed to achieving higher optimality for a narrow set of specialized
therapies.
Biological relevance of here analyzed MM system derives from the models by Komarova et al. [8] and
Koenders and Saso [9]. This model for studying tumor - bone interactions is built in accordance with the general
parsimony framework [64] which captures the fundamentals of the system. Presented approaches contribute to
the understanding of the respective nonlinear ODEs by analyzing their complex responses. The works which fo-
cus on the problem of cancer treatment and its modeling can be roughly divided along two principal therapeutic
targets: the tumor or its environment, respectively [28]. Our present work is in line with environmental aspect of
cancer progression which is profoundly stressed in evolutionary and ecological models of cancer [65, 66, 67, 12].
We hope that the methodology presented in this work will be extended to take into account intratumor hetero-
geneity [68, 69, 70], e.g. cell-to-cell heterogeneity at the MM level [71, 30, 36]. The indirect, environmentally
oriented therapies can cause the erosion of the habitats of the cancer clones, or, eventually, to decrease the prob-
ability of drug resistance. Many promising and innovated therapies exploit indirect therapeutic effects, such as
the cell cycle manipulation, influencing or remodeling of vascular networks [72, 73]. More specifically, in Ref.
[74] the authors identified indirect antimyeloma mechanisms preventing bone resorption [74]. Another exam-
ple which should be mentioned in this context is immunotherapy [50, 51, 75, 76], where particular emphasis is
placed on tumor-associated macrophages and cancer-associated fibroblasts as the determinants of the tumor mi-
croenvironment. The recent literature [77] reminds that homeostasis of normal bone tissue formed by OBs, OCs
and osteocytes is regulated predominantly by osteocyte cells derived from OBs. In the case of MM, homeostasis
is impaired, leading to the bone resorption, pathogenic lesions and tumor expansion. We assume that this type of
knowledge can be appropriately integrated into the three-component form of the environmental population with
eventual therapeutic influence on tumorigenesis.
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A Appendices
A.1 Robustness of the optimum, reoptimization in the periodic environment
The therapies can be delivered in periodic or other appropriate manner [48, 59] instead of in one time only. As an
alternative to focusing on the optimal number of the pulse repeats, we investigate the feasibility and robustness
of the periodic extension of the results achieved for single pulse [see sec.3.3] without reoptimization for the
periodic conditions. The extension represents a kind of myopic, short-term strategy [78].
Technically, the extension we applied is based on smin and period tE−tS . The transient, not purely periodic,
C(t), B(t), T (t), J(t) responses are obtained when the integration of Eqs.(1), (2) is performed for the sequence
of the joint intervals 〈t(per)0 (m), t(per)1 (m)〉, where m = 0, 1, 2, . . . are indices of the periodic shifts t(per)0 (m) =
t0 + m(tE − tS), t(per)1 (m) = t1 + m(tE − tS) in the locations of the peaks replacing t0, t1 in the functions
ψ(t, t0 → t(per)0 (m), . . .) and ψ(t, t1 → t(per)1 (m), . . .).
From Figs.(10) and (11) we see that despite the optimization has not been performed in the periodic case and
only suboptimal smin has been used, it turns out that the therapeutic interventions obtained are sufficient to keep
tumors within safe limits.
A.2 Stability of integrators
In the numerical ODE analysis, the explicit integration methods assume that almost any numerical precision
can be achieved by selecting small enough integration step. Therefore, if the explicit methods, such as the
above mentioned RK4 are applied, great care must be taken to guarantee the convergence and the asymptotic
properties of iterates, as these may exhibit strong dependence on the integration step size. More specifically, the
problem known as ODE stiffness occurs in the cases where approximate errors of the numerical method cannot
be sufficiently suppressed regardless of how small the integration step is. Therefore, robust implicit integrators
need to be used to verify solutions obtained using explicit methods. For the ODE application described above
we perform combined problem-specific testing using the overall integration-optimization procedure instead of
purely numerical integration without locating optima. The aim of the combined testing [see Fig.12] is to examine
the persistence of min f (and the related metrics Dfmin), as well as revealing potential stiffness artifacts.
In Table 9 we list the thresholds in the parameter ∆t which indicate the onset of instabilities of the respec-
tive integrators. The numerical findings for RK4 are provided along with Euler predictor-corrector (PEC) and
PECECE variants with recurrent corrector steps. Both alternative integrators can be classified as implicit due to
the incorporation of the trapezoidal rule. By comparing the tabulated thresholds obtained for several Q we have
obtained a universal lower estimate of ∆t ∼ O( 0.01). It is obvious that the use of this or smaller step size does
not pose the risk of substantial stiffness errors for any of the above methods, which agree in smin. This means
that our original choice of ∆t = 5× 10−4 for RK4 provided reliable results.
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Q RK4 RK4 PEC PEC PECECE PECECE
rtol rtol rtol rtol rtol rtol
= 10−3 = 2× 10−3 = 10−3 = 2× 10−3 = 10−3 = 2× 10−3
0.1 0.496 0.966 0.530 1.036 0.506 1.025
0.4 0.116 0.219 0.146 0.279 0.146 0.291
1.0 0.024 0.045 0.042 0.077 0.042 0.077
3.0 0.022 0.038 0.158 0.248 0.276 0.303
Table 9: The table contains list of the threshold values of the parameter ∆t defined as the lowest values for
which the relative change of min f reaches at least the predefined levels of relative tolerance rtol = 10−3 (or
2×10−3) with respect to the reference (saturated) value of min f obtained for sufficiently small ∆t = 5×10−4.
We see that PEC stability exceeds those of RK4, moreover, adding another iteration loop within PECECE seems
to be even redundant for given parameters and intervals studied. The advantage of implicit methods is more
obvious at Q = 1, where the instabilities are stronger (see Fig.5). The calculations are performed for n0 = 0.
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Figure 2: The dynamic elements of the sensitivity analysis generated by the translation and scaling of the argu-
ments of the Gaussian pulses from Eq.(17). The calculation is based on the parameters t0, ξ0, t1, ξ1, σ0 defined
by Eqs.(25) and (26). The positions of t = t0 are indicated by the vertical arrows. The examples of four child
wavelets Eq.(16) used to construct ΨB(t) (corresponding to sI = 0) and ΨC(t, sI) (for sI ∈ Ω(4)).
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Figure 3: The motivation for the optimization. The figure panels calculated for different constraints, n0 = 0
(panels (a), (b)) and n0 = 2 (panels (c), (d)) The values of the objective function f(tS , tE , s) are calculated for
all strings s ∈ Ω and plotted as the function of Q. The results reveal the existence of parametric (and constraint
dependent) threshold Qthr(n0) above which the therapeutic effect f(.) < 1 exists when the optimization is
applied. The details of the threshold neighborhoods are shown in the panels (b), (d). In all cases the stability
line f = 1 separates unstable (unst.) from stable (stab.) regions. The highly unstable region f > 2 was removed
from the plot.
35
 0
 0.2
 0.4
 0.6
 0.8
 1
 1.2
 0.01  0.1  1
[0.042,1]
Qthr
m
in
 f
Q
n0=0
n0=1
n0=2
n0=3
n0=4
n0=5
1
 0.9
 0.92
 0.94
 0.96
 0.98
 1
 1.02
 1.04
 1.06
 0.03  0.04  0.05  0.06  0.07
Qthr
min f=min fJ
min f=min fT
m
in
 f, 
mi
n f
T,
 
m
in
 f J
Q
min fT
min fJ
min f
1
(a) (b) detail, n0 = 0
Figure 4: The plot of the optimized f(s). Panel (a) shows the min f dependencies on Q calculated for six
constraints n0 = 0, 1, . . . , 5. It means that strictly one discrete component among shCT , sgCC , sgCB , shBT ,
sgBC , sgBB is requested to be nonzero in the case of n0 = 5 constraint. The result that higher n0 leads to lower
efficiency of the virtual therapies (especially for high Q) is in agreement with intuitive reasoning. However, the
peaked form of the fmin(Q) at high Q lacks the intuitive understanding. It can be understood as a kind of the
combined effect of the optimization, high amplitude stimuli and nonlinearities of ODEs system. Panel (b) sheds
light on the problem of threshold Qthr where f(Qthr) = 1. The careful analysis shows that it is close but not
identical to the point min fT = min fJ where the objects of the optimization [larger function from the pair fT ,
fJ , see Eq.(19)] exchange.
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Figure 5: The panels show differences between the applied optimization criteria expressed by the functions fT
and fJ calculated for different n0. The differences in the minima of fT and fJ are quantified by means of the
Hamming distance dH,smin. The objective function values are reflected by the diversity measure Dfmin [see
panel (b)] defined by Eq.(23). The subtle difference between the threshold position Qthr (for n0 = 0) and the
minimum of Dfmin obtained for n0 = 0 has been already explained in the Fig.3. The highest diversity occurs at
the large Q.
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Figure 6: Q and pL dependencies of dL,smin distances introduced to analyze relative stability of the optima of the
alternative scalarizations discussed in the section 4. The panels (b), (d), (f), (g), (h) show that increasing positive
values of pL results in gradual vanishing of instability, in agreement with the expectation (we note that the worst-
case scenario corresponds to pL →∞). The distances calculated for the negative pL values −1,−2,−5 [panels
(a) ,(c), (e)] are nearly identical to each other. Specifically, the choice of small Q can guarantee higher stability,
thus lowering sensitivity to the way in which the scalarization is performed. Calculated for the constraint n0 = 0.
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Figure 7: The Q-dependence of the optimized alternative objective function values f(tS , tE , smin, λ) [see
Eq.(29)] calculated for λ = 0.0, 0.1, . . . , 1.0 [panel (a)] supplemented with multiple plots of 1− (1/6)(n0)min
quantity [panel (b)]. The plots demonstrate how the fraction of non-zero smin components varies with Q.
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Figure 10: The illustrative treatment of the tumor by means of the periodic environmental changes. The compar-
ison for several Q values. The periodic extension of the solution obtained for Q = 0.5 is based on the optimal
string smin = [3,−1,+1 ,+1,−1,+1,−1] (optimized for the non-periodic case only). The "antithetical" virtual
therapy santith = [3,+1,−1,−1,+1,−1,+1] (where component∓1 is replaced by±1) has been chosen for the
comparative purposes. Note that this therapy is not necessarily the worst possible therapy obtained for Q = 0.5.
The neutral [no influence of ΨB(.) or ΨC(.) terms] choice calculated forQ = 0 corresponds to the tumor growth
without environmental moves.
42
 1.6
 1.8
 2
 2.2
 2.4
 2.6
 0  1  2  3  4  5  6  7
C
t
 189
 196
 203
 210
 217
 0  1  2  3  4  5  6  7
B
t
 13
 14
 15
 16
 17
 18
 0  1  2  3  4  5  6  7
T
t
 0.084
 0.096
 0.108
 0.12
 0.132
 0.144
 0.156
 0  1  2  3  4  5  6  7
J
t
Figure 11: The onset of the periodic dynamics of the four cell populations characterized by C,B, T, J (popu-
lation numbers per BMU) induced by the exogenous periodic stimuli with the period tE − tS . Calculated for
Q = 0.05 and the respective string smin = [3,−1,−1,+1,−1,+1,−1].
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Figure 12: This figure shows results of the combined testing with the typical loss of numerical stability cor-
responding to the optimized outputs of the RK4 method obtained by the gradually increasing time integration
step. Calculated for n0 = 0 and Q ∈ {0.1, 0.4, 1, 3}. Data in panels (a), (b), (e), (f) show min f while (c),(d)
panels show Dfmin quantity. As it is obvious from the panel (f), the instability may also have a one-sided char-
acter. Note that dependencies (a) - (e) look seemingly stochastic for ∆t ' 0.1, but detailed view reveals certain
regularity of patterns in this region.
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